Andrew Tofe

Andrew Tofe, PhD has over forty years of experience in developing and commercializing diagnostic and therapeutic products for bone disease and bone repair. This research and work in bone includes over 50 publications and patents. Dr. Tofe founded and served as President and Chief Executive Officer of CeraMed Dental, where he developed and brought to market three different types of bone substitutes, OsteoGraf®/N in 1990, OsteoGraf®/LD in 1994, PepGen P-15™ in 1999, and PepGen P-15 Flow in 2001. Dr. Tofe served as President and Chief Executive Officer from the transition of CeraMed Dental into Cerapedics, Inc until 2006.